openPR Logo
Press release

Global Antisense and RNAi Therapeutics Market Analysis, Trends, Price, Revenue & Forecast Until 2022

11-07-2017 10:37 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Hub

Market_Research_Hub

Market_Research_Hub

To Understand the Anticoagulation Therapy Industry Status worldwide, Market Research Hub (MRH) has included the latest future scenario report titled “Global Antisense and RNAi Therapeutics Market Report 2017”, to its vast database. This study offers data about the prime regions operating in this chemical sector, along with their production, consumption, revenue and market share details. Further, the intelligent report also anticipates that the market would grow with a rising profitable CAGR during the period 2017 to 2022.

Request Free Sample Report @ https://www.marketresearchhub.com/enquiry.php?type=S&repid=1364120

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Antisense and RNAi Therapeutics for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Antisense and RNAi Therapeutics market competition by top manufacturers/players, with Antisense and RNAi Therapeutics sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
Glaxo Smith Kline
Sanofi Aventis / Genzyme
Isis Pharmaceuticals/ Ionis Pharmaceuticals
Arbutus Biopharma Ltd.
Silence Therapeutics
Bio-Path Holdings Inc.
Calando Pharmaceuticals
ICo Therapeutics
Quark Pharmaceuticals
Rexhan Pharmaceuticals
Biomarin/Prosensa
Regulus Therapeutics
Rxi Pharmaceuticals
Silenseed
Dicerna Pharmaceuticals
Sirnaomics Inc

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
RNA interference
SiRNA
MiRNA
Antisense RNA

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Antisense and RNAi Therapeutics for each application, including
Oncology
Cardiovascular
Renal
Neurodegenerative
Respiratory
Genetic
Infectious Diseases

Browse Full Report with TOC @ https://www.marketresearchhub.com/report/global-antisense-and-rnai-therapeutics-sales-market-report-2017-report.html

Table of Content:
Global Antisense and RNAi Therapeutics Sales Market Report 2017
1 Antisense and RNAi Therapeutics Market Overview
1.1 Product Overview and Scope of Antisense and RNAi Therapeutics
1.2 Classification of Antisense and RNAi Therapeutics by Product Category
1.2.1 Global Antisense and RNAi Therapeutics Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Antisense and RNAi Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 RNA interference
1.2.4 SiRNA
1.2.5 MiRNA
1.2.6 Antisense RNA
1.3 Global Antisense and RNAi Therapeutics Market by Application/End Users
1.3.1 Global Antisense and RNAi Therapeutics Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Renal
1.3.5 Neurodegenerative
1.3.6 Respiratory
1.3.7 Genetic
1.3.8 Infectious Diseases
1.4 Global Antisense and RNAi Therapeutics Market by Region
1.4.1 Global Antisense and RNAi Therapeutics Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Antisense and RNAi Therapeutics Status and Prospect (2012-2022)
1.4.3 China Antisense and RNAi Therapeutics Status and Prospect (2012-2022)
1.4.4 Europe Antisense and RNAi Therapeutics Status and Prospect (2012-2022)
1.4.5 Japan Antisense and RNAi Therapeutics Status and Prospect (2012-2022)
1.4.6 Southeast Asia Antisense and RNAi Therapeutics Status and Prospect (2012-2022)
1.4.7 India Antisense and RNAi Therapeutics Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Antisense and RNAi Therapeutics (2012-2022)
1.5.1 Global Antisense and RNAi Therapeutics Sales and Growth Rate (2012-2022)
1.5.2 Global Antisense and RNAi Therapeutics Revenue and Growth Rate (2012-2022)
….continue

Enquire about this report @ https://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1364120

About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of pharmaceutical market forecast reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients and customers.

Contact Us
90 State Street,
Albany, NY 12207,
United States
Toll Free: 800-998-4852 (US-Canada)
Email: press@marketresearchhub.com
Website: https://www.marketresearchhub.com/
Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Antisense and RNAi Therapeutics Market Analysis, Trends, Price, Revenue & Forecast Until 2022 here

News-ID: 804964 • Views:

More Releases from Market Research Hub

Acrylate Polymers Market Share, Industry Analysis & Forecast Report 2019-2025
Acrylate Polymers Market Share, Industry Analysis & Forecast Report 2019-2025
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Acrylate Polymers Market Professional Survey Report 2019”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Acrylate Polymers Market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the
Abrasive Wheels & Discs Market Drivers, Segment by Regions and Growth Analysis, Leading Players : DEWALT, Shark,Benchmark Abrasives,Bosch,Hot Max Up to 2025
Abrasive Wheels & Discs Market Drivers, Segment by Regions and Growth Analysis, …
Market Research Hub (MRH) has recently uploaded a new study titled “Global Abrasive Wheels & Discs Market Professional Survey Report 2019” to its broad online storehouse. The global Abrasive Wheels & Discs Market conveniently covers prime factors motivating development and steering industry trends and demand scenarios. Readers can easily quantify market opportunities with the availability of information such as market sizing and market forecasting, thereby being able to analyze the
Oral Dosing Cups Market Analysis By Application 2025 | Top Players- Comar, Inc, Stiplastics S.A.S, Argo S.A, Gramb GmbH Kunststoffverarbeitung, Origin Pharma Packaging, Eastman Chemical Company, Yuyao Liantong Plastic & Mould Co., Ltd
Oral Dosing Cups Market Analysis By Application 2025 | Top Players- Comar, Inc, …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Oral Dosing Cups Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Oral Dosing Cups market. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section
Opthalmic Lenses Market 2019-2025|Major Players- ZEISS, HOYA, SHIMIZU, Rodenstock, MingYue, Conant, Wanxin, CHEMI, Nikon
Opthalmic Lenses Market 2019-2025|Major Players- ZEISS, HOYA, SHIMIZU, Rodenstoc …
Market Research Hub (MRH) has actively uploaded a smart research report titled “Global Opthalmic Lenses Market Insights, Forecast to 2025”, to its broad online database. The primary motive of this study is to impart vital details associated to development of the Opthalmic Lenses market*. The assessment includes brief knowledge about market size, Y-o-Y growth, market dynamics and competitive scenario expected to transform in the near future. Ever section of the

All 5 Releases


More Releases for RNA

Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand. Browse 156 Market Data Tables and 112 Figures spread through 175
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited. Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion. One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and